Furthermore, a separate study has suggested that the inhibition of TNF-α expression can lead to an upregulation of IL-33 in tumor cells, which in turn enhances the activity of DCs and cytotoxic T cells, thereby promoting anti-tumor immunity. Here, IL33 is linked to neoplasm.